Table 3 Quality of evidence.
Quality assessment | No of patients | Effect | Quality | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
No of studies | Design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | Test | Control | Relative (95% CI) | Absolute | |
CER | RCT | SeriousA | NS | NS | SeriousE | N | 509/536 (95%) | 416/534 (77.9%) | OR 5.44 (3.51 to 8.43) | 171 more per 1000 (from 146 to 188 more) | ⊕⊕OO |
14 studies | Low | ||||||||||
FEV1/FVC | RCT | SeriousA | NS | NS | SeriousB, E | SeriousC | 150 | 150 | – | MD 2.51 higher (-0.05 lower to 5.06 higher) | ⊕OOO |
4 studies | Very low | ||||||||||
FEV1% | RCT | SeriousA | NS | NS | SeriousD, E | N | 398 | 396 | – | MD 16.18 higher (12.6 to 19.76 higher) | ⊕OOO |
10 studies | Very low | ||||||||||
PaO2 | RCT | SeriousA | NS | NS | SeriousE | N | 284 | 282 | – | MD 1.12 higher (0.87 to 1.36 higher) | ⊕⊕OO |
7 studies | Low | ||||||||||
PaCO2 | RCT | SeriousA | NS | NS | SeriousE | N | 284 | 282 | – | MD 1.43 lower (1.65 to 1.21 lower) | ⊕⊕OO |
7 studies | Low | ||||||||||
FEV1 | RCT | SeriousA | NS | NS | SeriousB | N | 176 | 174 | – | MD 0.3 higher (0.18 to 0.42 higher) | ⊕⊕OO |
5 studies | Low | ||||||||||
FVC | RCT | SeriousA | NS | NS | SeriousE | N | 212 | 210 | – | MD 0.33 higher (0.21 to 0.45 higher) | ⊕⊕OO |
5 studies | Low | ||||||||||
Hemoglobin | RCT | SeriousA | NS | NS | SeriousB, E | N | 133 | 131 | MD 16.17 lower (20.84 to 11.51 lower) | ⊕OOO | |
3 studies | Very low |